InSphero is the only 3D in vitro model company with the platform and expertise to modernize drug safety and efficacy testing in a way that empowers researchers to reach their full potential. Our innovative spheroid-based models allow for more effective and safe therapies to get to the clinic faster due to our superior robustness, reliability, reproducibility, and scalability. InSphero’s goal is to help researchers fuel a new era of drug discovery through comprehensive products and services for: - Liver safety - Liver disease - Islet Biology - Oncology & Immunology
View Top Employees from InSpheroWebsite | http://www.insphero.com |
Revenue | $13 million |
Funding | $36.1 million |
Employees | 81 (81 on RocketReach) |
Founded | 2009 |
Phone | +41 44 515 04 90 |
Fax | +41 44 515 04 91 |
Technologies |
JavaScript,
HTML,
PHP
+30 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Biotechnology, 3D cell culture, Healthcare, Science and Engineering, Cell-based assays, Health Care, Drug screening, Medical, Toxicology |
Web Rank | 3 Million |
Keywords | Insphero, Hepatotoxicity Testing, Gravityplustm Kit, Insphero Dart, Handling Microtissues Well Plate |
Competitors | Greater Zurich Area, Organovo Holdings, Inc., REPROCELL Europe Ltd (formerly Reinnervate), StemoniX, Visikol |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 54 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular InSphero employee's phone or email?
The InSphero annual revenue was $13 million in 2024.
Jürg Gysi is the Chairman Board of Directors of InSphero.
81 people are employed at InSphero.
The NAICS codes for InSphero are [541, 32541, 3254, 54, 32, 325].
The SIC codes for InSphero are [873, 87].